Tržní kapitalizace společnosti T2 Biosystems Inc

Jaká je hodnota metriky Tržní kapitalizace společnosti T2 Biosystems Inc?

Hodnota metriky Tržní kapitalizace společnosti T2 Biosystems Inc je $10.39M

Jaká je definice metriky Tržní kapitalizace?

Tržní kapitalizace (Market cap) je tržní hodnotou vydaných akcií obchodované společnosti a rovná se ceně akcií v daném čase vynásobené počtem kusů vydaných akcií .

As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.

Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.

The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.

Čemu se věnuje společnost T2 Biosystems Inc?

t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www

Firmy s metrikou tržní kapitalizace podobnou společnosti T2 Biosystems Inc

  • Hodnota metriky Tržní kapitalizace společnosti Global Vectra Helicorp je $10.38M
  • Hodnota metriky Tržní kapitalizace společnosti Willow Biosciences je $10.38M
  • Hodnota metriky Tržní kapitalizace společnosti MJ je $10.38M
  • Hodnota metriky Tržní kapitalizace společnosti FinTech Chain je $10.38M
  • Hodnota metriky Tržní kapitalizace společnosti mVISE AG je $10.39M
  • Hodnota metriky Tržní kapitalizace společnosti VerifyMe je $10.39M
  • Hodnota metriky Tržní kapitalizace společnosti T2 Biosystems Inc je $10.39M
  • Hodnota metriky Tržní kapitalizace společnosti Prime Intelligence Solutions je $10.40M
  • Hodnota metriky Tržní kapitalizace společnosti Titon Plc je $10.40M
  • Hodnota metriky Tržní kapitalizace společnosti Akar Auto Industries je $10.40M
  • Hodnota metriky Tržní kapitalizace společnosti Inditrade Capital je $10.40M
  • Hodnota metriky Tržní kapitalizace společnosti HKBridge je $10.41M
  • Hodnota metriky Tržní kapitalizace společnosti Chilean Metals je $10.41M